NEUROBEHAVIORAL DISINHIBITION

Clinical trials for NEUROBEHAVIORAL DISINHIBITION explained in plain language.

Never miss a new study

Get alerted when new NEUROBEHAVIORAL DISINHIBITION trials appear

Sign up with your email to follow new studies for NEUROBEHAVIORAL DISINHIBITION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug trial targets uncontrollable anger after head trauma

Symptom relief Completed

This study tested whether an investigational drug called AVP-786 could help reduce severe behavioral problems like aggression, agitation, and irritability in people who have had a traumatic brain injury (TBI). 168 participants were randomly assigned to receive either the drug or …

Matched conditions: NEUROBEHAVIORAL DISINHIBITION

Phase: PHASE2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief

Last updated Apr 01, 2026 14:41 UTC

NEUROBEHAVIORAL DISINHIBITION

Get alerted when new NEUROBEHAVIORAL DISINHIBITION trials appear

New drug trial targets uncontrollable anger after head trauma